DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

Glaxo's Ebola Candidate Well-Tolerated in Early U.S. Study - Analyst Blog

Health Care Sector Update for 11/28/2014: ALXN, NVS, DVAX

Avanir's Migraine Drug Gets Complete Response Letter - Analyst Blog

Avanir's Migraine Drug Gets Complete Response Letter - Analyst Blog

10 Sector Dividend Leaders Flash 12% To 58% November Upsides

AstraZeneca's (AZN) Respiratory Drug Approved in the EU - Analyst Blog

3 Value Stocks Near 52-Week Lows Worth Buying

These three value stocks may have taken it on the chin recently, but they could be poised for a quick rebound.

Merck Buys Rights to Ebola Vaccine Candidate from NewLink - Analyst Blog

Rolling With Biotech's Regulatory Punches: Chen Lin

BioMarin Takes Aim at Sarepta

BioMarin's acquisition of Prosensa puts it in direct competition with Sarepta.

Merck obtains right to experimental Ebola vaccine

See More Articles...